Viewing Study NCT04106856


Ignite Creation Date: 2025-12-24 @ 11:16 PM
Ignite Modification Date: 2026-01-17 @ 9:11 AM
Study NCT ID: NCT04106856
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-04-06
First Post: 2019-09-25
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Losartan and Hypofractionated Rx After Chemo for Tx of Borderline Resectable or Locally Advanced Unresectable Pancreatic Cancer (SHAPER)
Sponsor: University of Utah
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module